The CDC's Advisory Committee on Immunization Practices (ACIP) has voted by 8 to 3 to remove the recommendation that all ...

At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy ...

The EMBOLD study of relutrigine (also known as PRAX-562) was testing the oral drug in patients with SCN2A and SCN8A ...

Protego Biopharma is poised to start pivotal trials of its amyloid light-chain (AL) amyloidosis drug candidate, thanks to a ...

CD19-targeted therapy Breyanzi (lisocabtagene maraleucel) can now be used to treat adults with MZL – a rare and form of ...

The verdict is the latest twist in patent litigation between MSD and Halozyme, in which the latter is claiming that Keytruda ...

Seven digital health technologies (DHTs) that can be used to support people recovering from cardiovascular diseases have been ...

Despite their readiness, blood centres remain an underutilised lever in pharma’s innovation model. As industry players seek ...

FDA Commissioner Marty Makary has appointed Tracy Beth Høeg as acting director of the Center for Drug Evaluation and Research ...

Eli Lilly's fast-growing blood cancer drug Jaypirca has bagged a new FDA approval as an earlier treatment for relapsed or ...

For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug ...

VTx-002 is described as a first-in-class vectorised antibody targeting molecular pathways involving TAR DNA-binding protein ...